| 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the … M Humbert, G Kovacs, MM Hoeper, R Badagliacca, RMF Berger, M Brida, ... European heart journal 43 (38), 3618-3731, 2022 | 1699 | 2022 |
| Risk factors for perioperative complications in patients undergoing laparoscopic cholecystectomy: analysis of 22,953 consecutive cases from the Swiss Association of … UF Giger, JM Michel, I Opitz, DT Inderbitzin, T Kocher, L Krähenbühl, ... Journal of the American College of Surgeons 203 (5), 723-728, 2006 | 401 | 2006 |
| Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ T Powles, J Bellmunt, E Comperat, M De Santis, R Huddart, Y Loriot, ... Annals of Oncology 33 (3), 244-258, 2022 | 370* | 2022 |
| Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international … RA Stahel, O Riesterer, A Xyrafas, I Opitz, M Beyeler, A Ochsenbein, ... The Lancet Oncology 16 (16), 1651-1658, 2015 | 212 | 2015 |
| ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma A Scherpereel, I Opitz, T Berghmans, I Psallidas, M Glatzer, D Rigau, ... European respiratory journal 55 (6), 2020 | 205 | 2020 |
| Influence of inter-observer delineation variability on radiomics stability in different tumor sites M Pavic, M Bogowicz, X Würms, S Glatz, T Finazzi, O Riesterer, J Roesch, ... Acta Oncologica 57 (8), 1070-1074, 2018 | 179 | 2018 |
| Functional inactivation of NF2/merlin in human mesothelioma C Thurneysen, I Opitz, S Kurtz, W Weder, RA Stahel, E Felley-Bosco Lung cancer 64 (2), 140-147, 2009 | 171 | 2009 |
| A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the “SMART” approach for resectable malignant pleural mesothelioma BCJ Cho, R Feld, N Leighl, I Opitz, M Anraku, MS Tsao, DM Hwang, ... Journal of thoracic oncology 9 (3), 397-402, 2014 | 150 | 2014 |
| EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach AG Nicholson, JL Sauter, AK Nowak, HL Kindler, RR Gill, M Remy-Jardin, ... Journal of Thoracic Oncology 15 (1), 29-49, 2020 | 147 | 2020 |
| Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma? T Frauenfelder, M Tutic, W Weder, RP Götti, RA Stahel, B Seifert, I Opitz European Respiratory Journal 38 (1), 162-168, 2011 | 127 | 2011 |
| The IASLC Mesothelioma Staging Project: proposals for revisions of the N descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma D Rice, K Chansky, A Nowak, H Pass, H Kindler, L Shemanski, I Opitz, ... Journal of Thoracic Oncology 11 (12), 2100-2111, 2016 | 117 | 2016 |
| Management of malignant pleural mesothelioma—The European experience I Opitz Journal of thoracic disease 6 (Suppl 2), S238, 2014 | 113 | 2014 |
| The IASLC lung cancer staging project: analysis of resection margin status and proposals for residual tumor descriptors for non–small cell lung cancer JG Edwards, K Chansky, P Van Schil, AG Nicholson, S Boubia, ... Journal of Thoracic Oncology 15 (3), 344-359, 2020 | 111 | 2020 |
| Combined genetic and genealogic studies uncover a large BAP1 cancer syndrome kindred tracing back nine generations to a common ancestor from the 1700s M Carbone, EG Flores, M Emi, TA Johnson, T Tsunoda, D Behner, ... PLoS genetics 11 (12), e1005633, 2015 | 106 | 2015 |
| Prognostic significance of epithelial–mesenchymal transition in malignant pleural mesothelioma A Schramm, I Opitz, S Thies, B Seifert, H Moch, W Weder, A Soltermann European journal of cardio-thoracic surgery 37 (3), 566-572, 2010 | 102 | 2010 |
| PTEN expression is a strong predictor of survival in mesothelioma patients I Opitz, A Soltermann, M Abaecherli, M Hinterberger, N Probst-Hensch, ... European journal of cardio-thoracic surgery 33 (3), 501-505, 2008 | 101 | 2008 |
| Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma I Opitz, P Kestenholz, D Lardinois, M Müller, V Rousson, D Schneiter, ... European journal of cardio-thoracic surgery 29 (4), 579-584, 2006 | 97 | 2006 |
| GAS5 long non-coding RNA in malignant pleural mesothelioma A Renganathan, J Kresoja-Rakic, N Echeverry, G Ziltener, B Vrugt, I Opitz, ... Molecular cancer 13, 1-12, 2014 | 96 | 2014 |
| Autologous fibrin sealant reduces the incidence of prolonged air leak and duration of chest tube drainage after lung volume reduction surgery: a prospective randomized blinded … C Moser, I Opitz, W Zhai, V Rousson, EW Russi, W Weder, D Lardinois The Journal of thoracic and cardiovascular surgery 136 (4), 843-849, 2008 | 91 | 2008 |
| A new prognostic score supporting treatment allocation for multimodality therapy for malignant pleural mesothelioma: a review of 12 years' experience I Opitz, M Friess, P Kestenholz, D Schneiter, T Frauenfelder, ... Journal of Thoracic Oncology 10 (11), 1634-1641, 2015 | 79 | 2015 |
